Immobilization of heparan sulfate on electrospun meshes to support embryonic stem cell culture and differentiation

Journal of Biological Chemistry

Volumn 288, Issue 8, 2013, Pages 5530-5538

  Meade, Kate A ^a   White, Kathryn J ^a,b   Pickford, Claire E ^a   Holley, Rebecca J ^c   Marson, Andrew ^a   Tillotson, Donna ^a   Van Kuppevelt, Toin H ^d   Whittle, Jason D ^e   Day, Anthony J ^c   Merry, Catherine L R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYL AMINE; ELECTROSPUNS; EMBRYONIC STEM CELLS; EXTRACELLULAR MATRICES; FUTURE APPLICATIONS; GLYCOSAMINOGLYCANS; HEPARAN SULFATES; REGENERATIVE MEDICINE;

BIOLOGICAL MATERIALS; BIOMATERIALS; STEM CELLS;

CELL IMMOBILIZATION;

FIBROBLAST GROWTH FACTOR 4; HEPARAN SULFATE; POLYGLACTIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; IMMOBILIZATION; IMMUNOCYTOCHEMISTRY; LIGAND BINDING; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN MOTIF; SULFATION; WILD TYPE; X RAY PHOTOELECTRON SPECTROSCOPY;

ALLYLAMINE; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; DISACCHARIDES; EMBRYONIC STEM CELLS; EPITOPES; GLYCOSAMINOGLYCANS; HEPARITIN SULFATE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, TRANSGENIC; OLIGOSACCHARIDES; PEPTIDE LIBRARY; POLYMERS; REGENERATION; REGENERATIVE MEDICINE;

EID: 84874318212     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.423012     Document Type: Article

References (50)

1. Ludwig, T. E., Levenstein, M. E., Jones, J. M., Berggren, W. T., Mitchen, E. R., Frane, J. L., Crandall, L. J., Daigh, C. A., Conard, K. R., Piekarczyk, M. S., Llanas, R. A., and Thomson, J. A. (2006) Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 24, 185-187
2. Baxter, M. A., Camarasa, M. V., Bates, N., Small, F., Murray, P., Edgar, D., and Kimber, S. J. (2009) Analysis of the distinct functions of growth factors and tissue culture substrates necessary for the long-term self-renewal of human embryonic stem cell lines. Stem Cell Res. 3, 28-38
3. Bateman, K. L., Delehedde, M., Sergeant, N., Wartelle, I., Vidyasagar, R., and Fernig, D. G. (2000) Heparan sulphate. Regulation of growth factors in the mammary gland. Adv. Exp. Med. Biol. 480, 65-69
4. Macri, L., Silverstein, D., and Clark, R. A. (2007) Growth factor binding to the pericellular matrix and its importance in tissue engineering. Adv. Drug Deliv. Rev. 59, 1366-1381
5. Harmer, N. J. (2006) Insights into the role of heparan suphate in fibroblast growth factor signalling. Biochem. Soc. Trans. 34, 442-445
6. Esko, J. D., and Lindahl, U. (2001) Molecular diversity of heparan sulfate. J. Clin. Invest. 108, 169-173
7. Johnson, C. E., Crawford, B. E., Stavridis, M., Ten Dam, G., Wat, A. L., Rushton, G., Ward, C. M., Wilson, V., van Kuppevelt, T. H., Esko, J. D., Smith, A., Gallagher, J. T., and Merry, C. L. (2007) Essential alterations of heparan sulfate during the differentiation of embryonic stem cells to Sox1-enhanced green fluorescent protein-expressing neural progenitor cells. Stem Cells 25, 1913-1923
8. Baldwin, R. J., ten Dam, G. B., van Kuppevelt, T. H., Lacaud, G., Gallagher, J. T., Kouskoff, V., and Merry, C. L. (2008) A developmentally regulated heparan sulfate epitope defines a subpopulation with increased blood potential during mesodermal differentiation. Stem Cells 26, 3108-3118
9. Pickford, C. E., Holley, R. J., Rushton, G., Stavridis, M. P., Ward, C. M., and Merry, C. L. (2011) Specific glycosaminoglycans modulate neural specification of mouse embryonic stem cells. Stem Cells 29, 629-640
10. Helledie, T., Dombrowski, C., Rai, B., Lim, Z. X., Hin, I. L., Rider, D. A., Stein, G. S., Hong, W., van Wijnen, A. J., Hui, J. H., Nurcombe, V., and Cool, S. M. (2012) Heparan sulfate enhances the self-renewal and therapeutic potential of mesenchymal stem cells from human adult bone marrow. Stem Cells Dev. 21, 1897-1910
11. Holley, R. J., Pickford, C. E., Rushton, G., Lacaud, G., Gallagher, J. T., Kouskoff, V., and Merry, C. L. (2011) Influencing hematopoietic differen-tiation of mouse embryonic stem cells using soluble heparin and heparan sulfate saccharides. J. Biol. Chem. 286, 6241-6252
12. Lam, H. J., Patel, S., Wang, A., Chu, J., and Li, S. (2010) In vitro regulation of neural differentiation and axon growth by growth factors and bioactive nanofibers. Tissue Eng. Part A 16, 2641-2648
13. Engler, A. J., Sen, S., Sweeney, H. L., and Discher, D. E. (2006) Matrix elasticity directs stem cell lineage specification. Cell 126, 677-689
14. Nur-E-Kamal, A., Ahmed, I., Kamal, J., Schindler, M., and Meiners, S. (2006) Three-dimensional nanofibrillar surfaces promote self-renewal in mouse embryonic stem cells. Stem Cells 24, 426-433
15. Kim, T. G., and Park, T. G. (2006) Biomimicking extracellular matrix: Cell adhesive RGD peptide modified electrospun poly(D,L-lactic-co-glycolic acid) nanofiber mesh. Tissue Eng. 12, 221-233
16. Nur-E-Kamal, A., Ahmed, I., Kamal, J., Babu, A. N., Schindler, M., and Meiners, S. (2008) Covalently attached FGF-2 to three-dimensional polyamide nanofibrillar surfaces demonstrates enhanced biological stability and activity. Mol. Cell Biochem. 309, 157-166
17. Sørensen, V., Nilsen, T., and Wiedlocha, A. (2006) Functional diversity of FGF-2 isoforms by intracellular sorting. Bioessays 28, 504-514
18. Pike, D. B., Cai, S., Pomraning, K. R., Firpo, M. A., Fisher, R. J., Shu, X. Z., Prestwich, G. D., and Peattie, R. A. (2006) Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 27, 5242-5251
19. Park, K., Cho, K. J., Kim, J. J., Kim, I. H., and Han, D. K. (2009) Functional PLGA scaffolds for chondrogenesis of bone-marrow-derived mesenchymal stem cells. Macromol. Biosci. 9, 221-229
20. Mahoney, D. J., Whittle, J. D., Milner, C. M., Clark, S. J., Mulloy, B., Buttle, D. J., Jones, G. C., Day, A. J., and Short, R. D. (2004) A method for the non-covalent immobilization of heparin to surfaces. Anal. Biochem. 330, 123-129
21. Marson, A., Robinson, D. E., Brookes, P. N., Mulloy, B., Wiles, M., Clark, S. J., Fielder, H. L., Collinson, L. J., Cain, S. A., Kielty, C. M., McArthur, S., Buttle, D. J., Short, R. D., Whittle, J. D., and Day, A. J. (2009) Development of a microtiter plate-based glycosaminoglycan array for the investigation of glycosaminoglycan-protein interactions. Glycobiology 19, 1537-1546
22. Robinson, D. E., Buttle, D. J., Short, R. D., McArthur, S. L., Steele, D. A., and Whittle, J. D. (2012) Glycosaminoglycan (GAG) binding surfaces for characterizing GAG-protein interactions. Biomaterials 33, 1007-1016
23. Aviss, K. J., Gough, J. E., and Downes, S. (2010) Aligned electrospun polymer fibres for skeletal muscle regeneration. Eur. Cell Mater. 19, 193-204
24. Deakin, J. A., and Lyon, M. (2008) A simplified and sensitive fluorescent method for disaccharide analysis of both heparan sulfate and chondroitin/ dermatan sulfates from biological samples. Glycobiology 18, 483-491
25. Holley, R. J., Deligny, A., Wei, W., Watson, H. A., Niñonuevo, M. R., Dagälv, A., Leary, J. A., Bigger, B. W., Kjellén, L., and Merry, C. L. (2011) Mucopolysaccharidosis type I, unique structure of accumulated heparan sulfate and increased N-sulfotransferase activity in mice lacking α-l-iduronidase. J. Biol. Chem. 286, 37515-37524
26. Parkar, A. A., Kahmann, J. D., Howat, S. L., Bayliss, M. T., and Day, A. J. (1998) TSG-6 interacts with hyaluronan and aggrecan in a pH-dependent manner via a common functional element: Implications for its regulation in inflamed cartilage. FEBS Lett. 428, 171-176
27. Mahoney, D. J., Mulloy, B., Forster, M. J., Blundell, C. D., Fries, E., Milner, C. M., and Day, A. J. (2005) Characterization of the interaction between tumor necrosis factor-stimulated gene-6 and heparin: Implications for the inhibition of plasmin in extracellular matrix microenvironments. J. Biol. Chem. 280, 27044-27055
28. Robinson, D. E., Marson, A., Short, R. D., Buttle, D. J., Day, A. J., Parry, K. L., Wiles, M., Highfield, P., Mistry, A., and Whittle, J. D. (2008) Surface gradient of functional heparin. Advanced Materials 20, 1166-1169
29. van Kuppevelt, T. H., Dennissen, M. A., van Venrooij, W. J., Hoet, R. M., and Veerkamp, J. H. (1998) Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J. Biol. Chem. 273, 12960-12966
30. Lin, X., Wei, G., Shi, Z., Dryer, L., Esko, J. D., Wells, D. E., and Matzuk, M. M. (2000) Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. Dev. Biol. 224, 299-311
31. Ying, Q. L., Stavridis, M., Griffiths, D., Li, M., and Smith, A. (2003) Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat. Biotechnol. 21, 183-186
32. Merry, C. L., Bullock, S. L., Swan, D. C., Backen, A. C., Lyon, M., Beddington, R. S., Wilson, V. A., and Gallagher, J. T. (2001) The molecular phenotype of heparan sulfate in the Hs2st-/-mutant mouse. J. Biol. Chem. 276, 35429-35434
33. Lamanna, W. C., Baldwin, R. J., Padva, M., Kalus, I., Ten Dam, G., van Kuppevelt, T. H., Gallagher, J. T., von Figura, K., Dierks, T., and Merry, C. L. (2006) Heparan sulfate 6-O-endosulfatases: Discrete in vivo activities and functional cooperativity. Biochem. J. 400, 63-73
34. Stevens, M. M., and George, J. H. (2005) Exploring and engineering the cell surface interface. Science 310, 1135-1138
35. Barry, J. J., Silva, M. M., Shakesheff, K. M., Howdle, A. M., and Alexander, M. (2005) Plasma deposits to promote cell population of the porous interior of three-dimensional poly(D,L-lactic acid) tissue-engineering scaffolds. Advanced Functional Materials 15, 1134-1140
36. Beamson, G., and Briggs, D. (1992) High Resolution XPS of Organic Polymers, Wiley, New York
37. Shard, A. G., Whittle, J. D., Beck, A. J., Brookes, P. N., Bullett, N. A., Talib, R. A., Mistry, A., Barton, D., and McArthur, S. L. (2004) A NEXAFS examination of unsaturation in plasma polymers of allylamine and propylamine. J. Phys. Chem. B 108, 12472-12480
38. Smits, N. C., Lensen, J. F., Wijnhoven, T. J., Ten Dam, G. B., Jenniskens, G. J., and van Kuppevelt, T. H. (2006) Phage display-derived human antibodies against specific glycosaminoglycan epitopes. Methods Enzymol. 416, 61-87
39. Ten Dam, G. B., Kurup, S., van de Westerlo, E. M., Versteeg, E. M., Lindahl, U., Spillmann, D., and van Kuppevelt, T. H. (2006) 3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. J. Biol. Chem. 281, 4654-4662
40. Wijnhoven, T. J., van de Westerlo, E. M., Smits, N. C., Lensen, J. F., Rops, A. L., van der Vlag, J., Berden, J. H., van den Heuvel, L. P., and van Kuppevelt, T. H. (2008) Characterization of anticoagulant heparinoids by immunoprofiling. Glycoconj. J. 25, 177-185
41. Yang, Z., Tu, Q., Wang, J., and Huang, N. (2012) The role of heparin binding surfaces in the direction of endothelial and smooth muscle cell fate and re-endothelialization. Biomaterials 33, 6615-6625
42. Stavridis, M. P., Lunn, J. S., Collins, B. J., and Storey, K. G. (2007)Adiscrete period of FGF-induced Erk1/2 signalling is required for vertebrate neural specification. Development 134, 2889-2894
43. Smith, R. A., Meade, K., Pickford, C. E., Holley, R. J., and Merry, C. L. (2011) Glycosaminoglycans as regulators of stem cell differentiation. Biochem. Soc. Trans. 39, 383-387
44. Clark, S. J., Higman, V. A., Mulloy, B., Perkins, S. J., Lea, S. M., Sim, R. B., and Day, A. J. (2006) His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form. J. Biol. Chem. 281, 24713-24720
45. Gallagher, J. T. (2001) Heparan sulfate: Growth control with a restricted sequence menu. J. Clin. Invest. 108, 357-361
46. Xu, Y., Masuko, S., Takieddin, M., Xu, H., Liu, R., Jing, J., Mousa, S. A., Linhardt, R. J., and Liu, J. (2011) Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins. Science 334, 498-501
47. Xu, R. H., Peck, R. M., Li, D. S., Feng, X., Ludwig, T., and Thomson, J. A. (2005) Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat. Methods 2, 185-190
48. Kurpinski, K. T., Stephenson, J. T., Janairo, R. R., Lee, H., and Li, S. (2010) The effect of fiber alignment and heparin coating on cell infiltration into nanofibrous PLLA scaffolds. Biomaterials 31, 3536-3542
49. Spadaccio, C., Rainer, A., Centola, M., Trombetta, M., Chello, M., Lusini, M., Covino, E., Toyoda, Y., and Genovese, J. A. (2010) Heparin-releasing scaffold for stem cells: A differentiating device for vascular aims. Regen. Med. 5, 645-657
50. Fan, V. H., Tamama, K., Au, A., Littrell, R., Richardson, L. B., Wright, J. W., Wells, A., and Griffith, L. G. (2007) Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells. Stem Cells 25, 1241-1251